D-783
Determination of Lidocaine and Phenoxyethanol by HPLC using UV-Vis Spectroscopy
Original Document
Scanned document (image-only PDF)
Extracted Text
Searchable text extracted from PDF
1.0 Purpose
The purpose of this procedure is to define the method for the quantification and identification
of Lidocaine and Phenoxyethanol in raw materials and finished products by HPLC/UV.
2.0 Scope
The procedure applies to the identification and quantification of Lidocaine and Phenoxyethanol
in raw materials and finished products by HPLC/UV, specifically in drug product DCRO00013.
3.0 Responsibility
3.1 It is the responsibility of QC Chemists to follow this procedure.
It is the responsibility of QC Laboratory Management to ensure that this procedure is
3.2 being followed.
It is the responsibility of QC Laboratory Management and/or Analytical Development
3.3 Personnel to keep this procedure aligned with current practices.
4.0 Definitions
HPLC/UV — High Pressure Liquid Chromatography with Ultraviolet Detection
4.1 4.2 QC — Quality Control
4.3 CofA — Certificate of Analysis
[SOP
Standard Operating Procedure SOP No | Rev
Determination of Lidocaine and Phenoxyethanol D-783 1 age
2 of7
by HPLC using UV/VIS Spectroscopy
4.4 LDC — Lidocaine
4.5 POE — 2-Phenoxyethanol
4.6 DMA -— 2,6-Dimethylaniline HCl
4.7 Euxyl® PE9010 — A preservative blend containing 90% Phenoxyethanol
4.8 ACN — Acetonitrile
4.9 H3PO4 — 85% Phosphoric Acid
4.10 H20 — Deionized water
5.0 References
5.1 MV-LAB-19-062 Validation of an Analytical Method for the Determination of
Lidocaine by HPLC/UV
6.0 Supplies
6.1 Chemicals: All reagents are HPLC grade or better
6.1.1 LDC Reference Standard
6.1.2 POE Reference Standard
6.1.3 DMA
6.1.4 ACN
6.1.5 H3PO4
6.2 Glassware
6.2.1 Volumetric glassware as required for standard and sample preparations
6.3 Equipment
6.3.1 Suitable gradient HPLC system consisting of a pump, autosampler, column oven
and UV detector with a chromatographic data handling system
6.3.2 Analytical Balance
6.3.3 Centrifuge
[SOP
Standard Operating Procedure SOP No | Rev
Determination of Lidocaine and Phenoxyethanol D-783 : Page
3 of 7
by HPLC using UV/VIS Spectroscopy
6.3.4 Adjustable Pipette
7.0 Procedure
El Mobile Phase Preparation
deka Mobile Phase A
7.1.1.1 Combine 1000 mL of H20 with 1.0 mL of H3PO,
(a Mobile Phase B
7.1.2.1 ACN
Eis Extraction Solvent
7.1.3.1 Combine 500 mL Water with 500 mL ACN
7.1.4 Diluent
7.1.4.1 Combine 900 mL of MP-A with 100 mL of CAN
7.1.5 Scale all mobile phases, extraction solvents and diluent as needed.
7.2 Standard Preparation
7.2.1 Standard solutions are stable for two days at room temperature.
eee Dilutions should be prepared using volumetric glassware.
7.2.3 Standard preparation may be scaled up as required. Scaling down is generally
not recommended.
7.2.4 LDC Stock: Transfer 50 mg of LDC reference standard (or 61.6 mg of
LDC*HCl monohydrate reference standard) into a 50-mL volumetric flask.
Dissolve in and dilute to volume with Extraction Solvent.
T,2ied POE Stock: Only prepare if quantifying POE. Use a pipet to transfer about
112.5 mg of POE reference standard directly into a 250-mL volumetric flask
taking care to direct the standard to the bottom of the flask without touching the
side. Dissolve in and dilute to volume with Extraction Solvent.
Fa2® DMA Stock: Transfer 40 mg of DMA to a 25-mL volumetric flask. Dissolve in
and dilute to volume with Extraction Solution. The DMA Stock does not expire
[SOP
Standard Operating Procedure SOP No | Rev
Determination of Lidocaine and Phenoxyethanol D-783 |
Page
4 of 7
by HPLC using UV/VIS Spectroscopy
and may be kept in the refrigerator until needed. If additional peaks are observed
in the chromatogram of the Working Standard, prepare a fresh DMA stock.
7.2.7 Working Standard: Transfer 4.0 mL of LDC Stock, 2.0 mL of POE Stock, and
1.0 mL of DMA Stock into a 100-mL volumetric flask. Dilute to volume with
Diluent.
ie Sample Preparation
7.3.1 LDC is stable in sample preparations at room temperature for one day. Samples
which require analysis of POE should be analyzed within 24 hours of
preparation.
7.3.2 Finished Products: For topical semi-solid dosage forms: based on the label
claim, transfer no less than 250 mg of the product into a suitably sized
volumetric flask of no less than 25 mL to generate a concentration of LDC that
is about 0.4 mg/mL and/or a concentration of POE that is about 0.09 mg/mL.
Dilute the sample to 2/3 of the flask volume with Extraction Solvent and shake
mechanically for 30 min or until the sample is completely dispersed. Dilute to
volume with Extraction Solvent. Transfer a 5.0 mL aliquot of the completely
dispersed sample into a 50-mL volumetric flask and dilute to volume with
Diluent. Filter a portion through a 0.45 um membrane discarding the first 3 mL.
ExamplTeh:e product contains 4% LDC and 1% Euxyl® PE9010
Euxyl® PE9010 contains 90% POE
Prepare 50 mL of a 0.4 mg/mL LDC and 0.09 mg/mL POE solution
0.4 mg/mL LDC + (4%/100%) x 50 mL = 500 mg
0.09 mg/mL POE + (90%/100%) + (1%/100%) x 50 mL = 500 mg
Dissolve 500 mg of sample in 50 mL of Diluent and filter
7.3.3. Raw Materials: For LDC determination, weigh no less than 40 mg of raw
material sample into a suitably sized volumetric flask to generate a
concentration of about 0.4 mg/mL Dissolve in and dilute to volume with diluent.
7.3.4 Perform further dilutions as required using diluent.
[SOP
Standard Operating Procedure SOP No Rev
D-783 1 Page
Determination of Lidocaine and Phenoxyethanol
5 of7
by HPLC using UV/VIS Spectroscopy
7.3.5 For finished products or raw materials being analyzed for the first time using
this method, an in process validation is required to demonstrate spectral purity,
baseline separation of peaks, and extraction efficiency as a part of system
suitability before data can be reported using this method.
7.4 HPLC Parameters
7.4.1 Column: Kinetex XB-C18, 5um, 4.6 mm x 150 mm
7.4.2 Column Temperature: 30 °C
74.3 Flow rate: 0.8 mL/min
TAA Wavelength: 220 nm with 4 nm bandwidth
7.4.5 Injection Volume: 5 uL
7.4.6 Run Time: 15 minutes
7.4.7 Spectral Range (for Identification)- 210 nm to 360 nm
74.8 Gradient Profile:
Time “MPA %MPB
0 90 10
10 10 90
10.1 90 10
15 90 10
7.5 Recommended Sequence
7.5.1 Make at least 2 injections of the diluent.
hoe Make five (5) injections of Standard Solution.
7.5.3 Make a single injection of each Sample Preparation.
7.5.4 Make a single injection of the Standard Solution after every ten (10) sample
injections or at the end of a run.
7.6 System Suitability Requirements
7.6.1 The %RSD of the first five (5) standard injections is NMT 2.0%.
7.6.2 The %RSD of all standard injections is NMT 3.0%.
[SOP
Standard Operating Procedure SOP No | Rev
Determination of Lidocaine and Phenoxyethanol D-783 {
Page
6 of 7
by HPLC using UV/VIS Spectroscopy
7.6.3 The average (n=5) tailing factor for LDC is NMT 1.5.
7.6.4 The average (n=5) resolution of DMA and LDC is NLT 1.8.
7.6.5 If present, any interference in the diluent should be subtracted out of the sample
and standard peak areas.
7.7. _Retention Times
7.7.1 DMA: RT = 4.23 min, RRT = 0.914
7.7.2 LDC: RT = 4.63 min, RRT = 1.000
7.7.3 POE: RT = 6.52 min, RRT = 1.408
7.8 Example calculations for determining finished product % label or raw material % purity
7.8.1 %assay= 4R x —WtstSq HX=P x —V P x —100
Rs Veta Splwt | LA
Ry Sample peak area
Rg Mean standard peak area
Wteta Weight of reference standard in mg (correct for moisture if required)
Vsta Volume of the standard preparation accounting for dilutions in mL
P Purity of the reference standard in percent
Spl we Sample weight in mg
Vspl Volume of the sample preparation accounting for dilutions in mL
LA Label amount in percent (use 1 for raw materials)
7.9 Column Wash and Storage
7.9.1 Rinse the column with H2O / ACN (80/20)
7.9.2 Store the column in H20 / ACN (50/50)
[SOP
Standard Operating Procedure SOP No | Rev °
Determination of Lidocaine and Phenoxyethanol D-783 I “ os
by HPLC using UV/VIS Spectroscopy
8.0 Revision History
| Rev | Date | Description of Changes | CCR # | By |
|-----|----------|------------------------|-------|----|
| 0 | 06/26/19 | New N/A S. Sassman | - | - |
| 1 | 07/21/22 | Scheduled review: updated logo and format. CC- | 22-0295 | _K. Burris |